Literature DB >> 1825915

Macrocytosis in Down syndrome.

T J Wachtel1, S M Pueschel.   

Abstract

The mean corpuscular volume of erythrocytes in persons with Down syndrome is larger than normal in the absence of anemia. The mean mean corpuscular volume among our 61 subjects with trisomy 21 was 99.08 fl (range = 90 to 107). Red blood cell survival half-time was substantially shorter than normal in many of these patients. These findings suggest that erythrocytes have a younger mean age in persons with Down syndrome. The increased red blood cell turnover in this population may indicate an accelerated aging process of red blood cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825915

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  10 in total

Review 1.  Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.

Authors:  Eugenio Barone; Andrea Arena; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2017-07-10       Impact factor: 7.376

2.  Red blood cell metabolism in Down syndrome: hints on metabolic derangements in aging.

Authors:  Rachel Culp-Hill; Connie Zheng; Julie A Reisz; Keith Smith; Angela Rachubinski; Travis Nemkov; Eric Butcher; Ross Granrath; Kirk C Hansen; Joaquín M Espinosa; Angelo D'Alessandro
Journal:  Blood Adv       Date:  2017-12-21

3.  Prevalence of iron deficiency in children with Down syndrome.

Authors:  Natalia E Dixon; Blythe G Crissman; P Brian Smith; Sherri A Zimmerman; Gordon Worley; Priya S Kishnani
Journal:  J Pediatr       Date:  2010-07-21       Impact factor: 4.406

4.  Cardiometabolic Risk and Body Composition in Youth With Down Syndrome.

Authors:  Sheela N Magge; Babette S Zemel; Mary E Pipan; Samuel S Gidding; Andrea Kelly
Journal:  Pediatrics       Date:  2019-07-17       Impact factor: 7.124

5.  Altered DNA methylation in leukocytes with trisomy 21.

Authors:  Kristi Kerkel; Nicole Schupf; Kota Hatta; Deborah Pang; Martha Salas; Alexander Kratz; Mark Minden; Vundavalli Murty; Warren B Zigman; Richard P Mayeux; Edmund C Jenkins; Ali Torkamani; Nicholas J Schork; Wayne Silverman; B Anne Croy; Benjamin Tycko
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

6.  Hematological abnormalities in adult patients with Down's syndrome.

Authors:  S McLean; C McHale; H Enright
Journal:  Ir J Med Sci       Date:  2008-11-20       Impact factor: 1.568

7.  Anemia in children with down syndrome.

Authors:  Ariel Tenenbaum; Sarah Malkiel; Isaiah D Wexler; Floris Levy-Khademi; Shoshana Revel-Vilk; Polina Stepensky
Journal:  Int J Pediatr       Date:  2011-09-14

8.  Association of the Single Nucleotide Polymorphisms in RUNX1, DYRK1A, and KCNJ15 with Blood Related Traits in Pigs.

Authors:  Jae-Bong Lee; Chae-Kyoung Yoo; Hee-Bok Park; In-Cheol Cho; Hyun-Tae Lim
Journal:  Asian-Australas J Anim Sci       Date:  2016-08-04       Impact factor: 2.509

9.  Deleterious Effects of Chronic Folate Deficiency in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Susan Helm; Morgan Blayney; Taylor Whited; Mahjabin Noroozi; Sen Lin; Semira Kern; David Green; Ahmad Salehi
Journal:  Front Cell Neurosci       Date:  2017-06-09       Impact factor: 5.505

10.  Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.

Authors:  Ayala Tovy; Carina Rosas; Amos S Gaikwad; Geraldo Medrano; Linda Zhang; Jaime M Reyes; Yung-Hsin Huang; Tastuhiko Arakawa; Kristen Kurtz; Shannon E Conneely; Anna G Guzman; Rogelio Aguilar; Anne Gao; Chun-Wei Chen; Jean J Kim; Melissa T Carter; Amaia Lasa-Aranzasti; Irene Valenzuela; Lionel Van Maldergem; Lorenzo Brunetti; M John Hicks; Andrea N Marcogliese; Margaret A Goodell; Rachel E Rau
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 11.047

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.